Respiratory Therapeutic Devices Market Research Report, By Product (Nebulizers, Humidifiers) By Technology (Electrostatic Filtration, HEPA) By Application (Asthma, COPD, Cystic Fibrosis) By End Users (Hospitals, Home Care) - Forecast till 2032

Table of Contents

1 Introduction

1.1 Definition

1.2 Scope of the study

1.2.1 Research Objectives

1.2.2 Assumptions & Limitations

1.3 Market Structure

2 Research Methodology

2.1 Research Process

2.2 Primary Reseacrh

2.3 Secondary Research

2.4 Forecast Model

3 Report Excerpt

4 Forecast Indicators

4.1 Introduction

4.2 Growth Drivers

4.3 Growth Barries

4.4 Recent Trends

4.5 Macroecnomical Indicators

5 Respiratory Therapeutic Devices Market, By Product

5.1 Introduction

5.2 PAP Devices

5.2.1 CPAP Devices

5.2.2 APAP Devices

5.2.3 BPAP Devices

5.3 Masks

5.3.1 Nasal Masks

5.3.2 Full-Face Masks

5.3.3 Nasal Pillow Masks

5.3.4 Oral Masks

5.4 Ventilators

5.4.1 Adult Ventilators

5.4.2 Infant Ventilators

5.5 Nebulizers

5.6 Humidifiers

5.6.1 Heated Humidifiers

5.6.2 Passover Humidifiers

5.7 Oxygen Concentrators

5.7.1 Fixed Oxygen Concentrators

5.7.2 Portable Oxygen Concentrators

5.8 Inhalers

5.8.1 Dry Powder Inhalers

5.8.2 Metered Dose Inhalers

5.9 Resuscitators

5.9.1 Reusable Resuscitators

5.9.2 Disposable Resuscitators

5.1 Nitric Oxide Delivery Units

5.11 Oxygen Hoods

5.12 Others

6 Respiratory Therapeutic Devices Market, By Mode of Care

6.1 Introduction

6.2 Hospital Care

6.3 Home Care

7 Geographical Exploration

7.1 Introduction

7.2 North America

7.2.1 USA

7.2.2 Canada

7.3 Latin America

7.3.1 Brazil

7.3.2 Columbia

7.3.3 Argentina

7.3.4 Rest of LATAM

7.4 Mexico

8 Competitive Analysis

8.1 Competitive/Strategic Scenario

8.2 Market Share Analysis

9 Company Profiles

9.1 ResMed, Inc.

9.1.1 Overview

9.1.2 Financials

9.1.3 Product Portfolio

9.1.4 Recent Developments

9.1.5 Business Strategies

9.2 Chart Industries (Airsep Corporation)

9.2.1 Overview

9.2.2 Financials

9.2.3 Product Portfolio

9.2.4 Recent Developments

9.2.5 Business Strategies

9.3 CareFusion Corporation

9.3.1 Overview

9.3.2 Financials

9.3.3 Product Portfolio

9.3.4 Recent Developments

9.3.5 Business Strategies

9.4 Covidien Plc

9.4.1 Overview

9.4.2 Financials

9.4.3 Product Portfolio

9.4.4 Recent Developments

9.4.5 Business Strategies

9.5 Fisher & Paykel Healthcare Limited

9.5.1 Overview

9.5.2 Financials

9.5.3 Product Portfolio

9.5.4 Recent Developments

9.5.5 Business Strategies

9.6 Koninklijke Philips N.V. (Philips Healthcare)

9.6.1 Overview

9.6.2 Financials

9.6.3 Product Portfolio

9.6.4 Recent Developments

9.6.5 Business Strategies

9.7 Masimo Corporation

9.7.1 Overview

9.7.2 Financials

9.7.3 Product Portfolio

9.7.4 Recent Developments

9.7.5 Business Strategies

9.8 Maquet Getinge Group

9.8.1 Overview

9.8.2 Financials

9.8.3 Product Portfolio

9.8.4 Recent Developments

9.8.5 Business Strategies

9.9 Invacare Corporation

9.9.1 Overview

9.9.2 Financials

9.9.3 Product Portfolio

9.9.4 Recent Developments

9.9.5 Business Strategies

9.1 GE Healthcare

9.10.1 Overview

9.10.2 Financials

9.10.3 Product Portfolio

9.10.4 Recent Developments

9.10.5 Business Strategies

10 Appendix